BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33742034)

  • 1. The factors influencing clinical outcomes after leukapheresis in acute leukaemia.
    Lee H; Park S; Yoon JH; Cho BS; Kim HJ; Lee S; Kim DW; Chung NG; Cho B; Kim KB; Yoo J; Jekarl DW; Chae H; Lim J; Kim M; Oh EJ; Kim Y
    Sci Rep; 2021 Mar; 11(1):6426. PubMed ID: 33742034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
    Kansal R
    Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
    Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
    Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
    J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
    Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
    Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
    Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
    Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia.
    Laporte JP; Douay L; Allieri A; Lopez M; Dupuy Montbrun MC; Mary JY; Giarratana MC; Isnard F; Najman A; Gorin NC
    Br J Haematol; 1990 Apr; 74(4):445-51. PubMed ID: 1971763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
    Kuo KH; Callum JL; Panzarella T; Jacks LM; Brandwein J; Crump M; Curtis JE; Gupta V; Lipton JH; Minden MD; Sher GD; Schimmer AD; Schuh AC; Yee KW; Keating A; Messner HA
    Br J Haematol; 2015 Feb; 168(3):384-94. PubMed ID: 25303497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-chemotherapy white blood cell depletion by therapeutic leukocytapheresis in leukemia patients: A single-institution experience.
    Nguyen TH; Bach KQ; Vu HQ; Nguyen NQ; Duong TD; De Reys S; Wheeler J
    J Clin Apher; 2020 Apr; 35(2):117-124. PubMed ID: 31829470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance.
    Wilhelmson AS; Porse BT
    Br J Haematol; 2020 Aug; 190(4):495-507. PubMed ID: 32086816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of therapeutic leukapheresis in hyperleukocytotic AML.
    Pastore F; Pastore A; Wittmann G; Hiddemann W; Spiekermann K
    PLoS One; 2014; 9(4):e95062. PubMed ID: 24733550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?
    Corbingi A; Putzulu R; Massini G; Colangelo M; Minnella G; Chiusolo P; Sica S; Piccirillo N
    Ann Hematol; 2023 Oct; 102(10):2735-2740. PubMed ID: 37592090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
    Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
    Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.